MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PHIO has $21,487K in assets. $1,340K in debts. $21,031K in cash and cash equivalents.

Balance Sheets Overview

Debt to Asset Ratio
6.24%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Less accumulated depreciation an...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
21,031
Prepaid expenses and other current assets
445
Total current assets
21,476
Property, plant and equipment, gross
239
Less accumulated depreciation and amortization
228
Property and equipment, net
11
Total assets
21,487
Accounts payable
435
Accrued expenses
905
Total liabilities
1,340
Common stock, 0.0001 par value, 100,000,000 shares authorized 11,617,250 and 1,733,717 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively
1
Additional paid-in capital
175,200
Accumulated deficit
-155,054
Total stockholders' equity
20,147
Total liabilities and stockholders' equity
21,487
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$21,031K Prepaid expenses andother current assets$445K Property, plant andequipment, gross$239K Total current assets$21,476K Property and equipment,net$11K Less accumulateddepreciation and...$228K Total assets$21,487K Total liabilities andstockholders' equity$21,487K Total stockholders'equity$20,147K Total liabilities$1,340K Accumulated deficit-$155,054K Additional paid-in capital$175,200K Accrued expenses$905K Accounts payable$435K Common stock, 0.0001par value,...$1K

Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Corp. (PHIO)